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The endoplasmic reticulum adapts to fluctuations in demand and copes with stress through an adaptive
signaling cascade called the unfolded protein response (UPR). Accumulating evidence indicates that the
canonicalUPRiscriticaltothesurvivalandfunctionofinsulin-producingpancreaticb-cells,andalterations
in the UPRmay contribute tothe pathogenesis of type 2diabetes.However, the dynamic regulation ofUPR
moleculesintheisletsofanimalmodelsandhumanswithtype2diabetesremainstobeelucidated.Here,we
analyzed the expression of activating factor 6 (ATF6a) and spliced X-box binding protein 1 (sXBP1), and
phosphorylation of eukaryoticinitiationfactor 2(eIF2a), toevaluatethethreedistinct branches oftheUPR
inthepancreaticisletsofmicewithdiet-orgenetic-inducedobesityandinsulinresistance.ATF6andsXBP1
expression was predominantly found in the b-cells, where hyperglycemia coincided with a decline in
expression in both experimental models and in humans with type 2 diabetes. These data suggest alterations
intheexpressionofUPRmediatorsmaycontributetothedeclineinisletfunctionintype2diabetesinmice
and humans.
T
heendoplasmicreticulum(ER)ishighlysensitivetothemicroenvironmentandaltersitsfunctionalcapacity
to meet the changing demands of the cell. Perturbations of the folding environment of the ER trigger an
adaptive signaling pathway known as the UPR. Activation of the UPR involves the engagement of three ER
membrane-resident proteins: PKR-like ER kinase (PERK), inositol requiring 1a (IRE1a), and activating tran-
scription factor 6a (ATF6a)
1. These proteins act as sensors of the ER microenvironment and initiate adaptive
responses to improve the functional capacity of the ER in response to stress. These adaptive responses include
translational inhibition, which is achieved by the PERK/eIF2a (eukaryotic initiation factor 2) arm of the UPR
pathway, and chaperone expression, which is supported by the induction of transcription factors ATF6a and the
splicedisoformofX-box-bindingprotein1(sXBP1),whichisgenerateddownstreamofIRE1activation.Together
withproteindegradationpathwayssuchasER-associateddegradation(ERAD)andautophagy,theadaptiveUPR
supports recovery from stress
1–3, which can be critical for maintaining cell function
4. However, prolonged and
unresolved stress can lead to a switch from adaptive to maladaptive or pro-apoptotic responses that are often
associated with pathological states
1–3.
Pancreatic b-cells are specialized secretory cells responsible for the production and secretion of insulin
in response to glucose fluctuations. Insulin biosynthesis and proper folding require healthy ER function
and an intact UPR
5–8. b-cell loss and the development of diabetes have been observed in multiple experimental
models where the UPR is compromised
9–20 and in humans with mutations in genes involved in ER
homeostasis
11,12,15,16,19,20.
AlthoughgeneticallyimpairedUPRfunctionhasbeenlinkedtob-celldeathanddiabetes,theregulationofthe
UPRcomponentsandtheroleoftheUPRwithinb-cellsatdifferentstagesoftype2diabetesinanimalmodelsand
humans has not been examined. Recent studies have demonstrated expression of some of the downstream
mediators of the UPR in b-cell lines or in isolated primary islets from type 2 diabetes animal models and human
patients,mainlyatthetranscriptlevel
21–24.However,questionsinthefieldhaveremainedinpartbecauseisolating
and culturing primary cells could induce stress responses that are not reflective of the in vivo context and mRNA
levels may not necessarily reflect the protein levels or provide insight into the posttranslational modifications of
UPR components that are required for their activity. Here, in order to gain further understanding of b-cell UPR
activation, we analyzed the protein levels of the main proximal regulators of the UPR- ATF6a, sXBP1, and
phosphorylatedeIF2a-insituduringdifferentstagesofdiabetesprogression.Wedetectedmarkedmodulationof
these pathways in pancreas sections from diabetic mouse models and human patients.
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To evaluate the potential modulation of the three branches of the
UPR in pancreatic islets during diabetes progression, we examined
the expression patterns of ATF6a, sXBP1, and P-eIF2a- at the pro-
tein level in situ by immunofluorescence. As a first step, we inter-
rogatedleptin-deficientob/obmiceat4weeksofage,astageatwhich
theyarenormoglycemic(Figure1a.),butinsulinresistantandhyper-
insulinemic (Figure 1b.). Staining of pancreas sections revealed that
expression of ATF6 and sXBP1 was markedly reduced in the islets of
ob/obmice, compared to age-matched wild type controls (Figure 1c.,
1d). These data suggest that during this period of b-cell compensa-
tion to insulin resistance, b-cells of ob/ob mice already exhibit a
significant reduction in the expression of critical UPR components.
Interestingly, we observed P-eIF2a localized primarily to the non-b-
cells of the islets, and in 4-week-old animals its expression was not
different between ob/ob and lean controls (Figure 1e.). The P-eIF2a
positive cells co-stained with glucagon (See Supplemental Fig. S1
online), suggesting that this branch of the UPR may be more highly
expressed in a-cells than in other islet populations.
Next, we stained pancreas sections from 8-week-old mice, an age
at which the ob/ob were profoundly hyperglycemic (Figure 1f.) and
hyperinsulinemic (Figure1g.).Atthis stage,ob/obmice continuedto
exhibit decreased ATF6a and sXBP1 levels (Figure 1h., 1i.). In con-
trast, P-eIF2a staining intensity was elevated in the a-cells of the
islets of obese mice at this age (Figure 1j.). It has been previously
demonstrated that ob/ob mice return to normoglycemia following a
transient period of hyperglycemia lasting 6-8 weeks
25,26. To examine
the influence of these changes on islet stress responses, we evaluated
ob/ob mice at 18 weeks of age, when they displayed normal glucose
levels despite maintaining elevated serum insulin (Figure 1k., 1l.).
Staining revealed that this improvement of glycemia was associated
with normalization of islet ATF6 and sXBP1 level (Figure 1m., 1n.).
Interestingly, the islet P-eIF2a level was no longer elevated in ob/ob
mice following this transition (Figure 1o.).
ToinvestigatethemodulationoftheisletUPRduringthedevelop-
ment of diet-induced insulin resistance, we placed male C57/BL6
mice on a high fat diet (HFD) that contained 60% kcal from fat.
Interestingly, although 1 week of HFD feeding was not sufficient to
Figure 1 | Expression of UPR mediators in the islets of ob/ob mice at different stages of the disease. (a). Fasting blood glucose of 4-week-old C57/BL6
andob/obmice(b).Fastingseruminsulinlevelof4-week-oldC57/BL6andob/obmice.Immunofluorescenceanalysiswasperformedinpancreassections
of 4-week-old C57/BL6 and ob/ob mice (n 5 4) by co-staining with (c). anti-ATF6a, (d). anti-sXBP1, or (e). anti-P-eIF2a (red) and anti-insulin (green)
antibodies. Quantification of relative fluorescence intensity (RFI) was performed on 10–20 islets per mouse and calculated using MATLABH (lower
panels). (f–j). Analysis of fasting insulin and glucose levels, and UPR mediator expression in 8-week-old C57/BL6 and ob/ob mice. (k–o). Analysis of 18
week-old mice as described above. All data are presented as mean 6 SEM, with statistical analysis performed by Student’s t test (***p , 0.001,
**p , 0.005, *p , 0.05).
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(Figure 2a.–c.), or ATF6 expression (Figure 2d.), the level of b-cell
sXBP1waselevatedatthisstage(Figure2e.),suggestingthatthisbrief
intervention induced b-cell stress. Similar to our observation in
young normoglycemic ob/ob mice, the level of P-eIF2a in a-cells
was not altered by HFD at this stage (Figure 2f.). After 13 weeks of
the diet manipulation, we observed significant increases in body
weight, blood glucose and serum insulin in HFD-fed mice
(Figure 2g.–i.). This was accompanied by a significant decline in
ATF6 staining intensity in b-cells (Figure 2j.), but a normalization
of the level of sXBP1 (Figure 2k.). P-eIF2a expression was signifi-
cantly increased in the islets at this stage (Figure 2l.).
The striking regulation of UPR components in the islets of mouse
models prompted us to examine these parameters in the pancreatic
islets of type 2 diabetics. We obtained pancreatic sections from 5
control and 8 diabetic donors (Table 1) and assessed the UPR using
Figure 2 | Expression of UPR markers in the islets of a diet induced animal model of obesity and insulin resistance. Wild type male mice (n 5 4 for each
group) were placed either on regular (chow) or high fat diet (HFD). (a–c). Analysis of body weight, fasting glucose, and serum insulin after one week on
diet. Immunofluorescence analysis was performed using (d). anti-ATF6 (red), (e). anti-sXBP1 (red), or (f). anti-P-eIF2a (red), and anti-insulin antibodies
(green). Quantification was performed on 10–20 islets per mouse. (g–l). Mice and pancreas sections were analyzed as above after 13 weeks on diet. Data are
presented as mean 6 SEM, with statistical analysis performed by Student’s t test (***p , 0.001, *p , 0.05).
Table 1 | Description of pancreatic donors
Patient Age Sex Ethnicity
Duration
of Diabetes BMI
C-peptide
(ng/ml) Histology
Ctrl 6.3 Female Hispanic N/A 18.4 5.11 Normal- excellent islet density. No
inflammation or fatty infiltrates
Ctrl 7.5 Female Hispanic N/A 16.3 1.7 Ins1/Gluc1 islets, normal
Ctrl 8.9 Female Hispanic N/A 24.2 12.13 Ins1 islets. Mild fatty infiltrate. No
inflammatory infiltrates
Ctrl 24 Female Hispanic N/A 22.6 No serum Normal islets. Mild fatty infiltrate. Low Ki67
Ctrl 72 Female Hispanic N/A 24.5 22.92 Ins1 normal islets. Low Ki67. Amyloid.
Exocrine atrophy w/fatty infiltrates
T2D 55.8 Female Hispanic Pre-clinical 44.6 0.8 Ins1 (reduced) islets. Low Ki67
T2D 48.8 Female Hispanic Pre-clinical 32.5 ,0.05 Ins1/Gluc1 islets (reduced). Amyloid. Low
Ki67. No fatty infiltrate despite high BMI.
T2D 18.8 Female Hispanic 0.25 yrs 39.1 10.68 Ins1 islets, single cells plentiful. Mild acinar
atrophy and pancreatic adipose tissue.
T2D 37.2 Female Hispanic 1.5 yrs 45.4 0.6 Ins1 islets plentiful with nuclear polymorphism.
Minimal fibrosis, no pancreatitis.
T2D 62 Female Caucasian 10 yrs 19.9 6.14 Ins1/Gluc1 plentiful islets, several with
amyloid.Severe,multifocalexocrineatrophy.
T2D 29.8 Female Hispanic 14 yrs 34.4 0.19 Ins1 islets (reduced), also as clusters and
single cells. Multifocal amyloid. Low Ki67.
T2D 39.3 Female African American 16 yrs 29.1 11.55 Ins1/Gluc1 islets numerous, some
hypertrophied. Islet amyloidosis.
T2D 45.8 Female Caucasian 20 yrs 40.2 0.84 Ins1islets,manyw/amyloid.Mild,interstitial
CD31 infiltrate. Severe exocrine atrophy.
Pancreatic sections were obtained from nPOD from these donors for immunofluorescence analysis of UPR mediators. Ins: Insulin, Gluc: Glucagon, Ab: Antibody.
www.nature.com/scientificreports
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and P-eIF2a stainingwasreadily detectableincontrol sectionsaswell
as those from patients with preclinical (PC) or early stage disease.
Although the expression of these UPR components was variable in
the T2D patients, cumulatively we observed a significant decrease in
ATF6a and sXBP1 expression in the islets of diabetic subjects
(Figure 3a., 3b.). This pattern is highly reminiscent of our observa-
tions in genetically obese mice, and supports the concept that a
deficient b-cell UPR response coincides with the emergence of frank
disease in both mouse and human. Interestingly, the level of P-eIF2a
was reduced in the islets of most diabetic patients (Figure 3c.).
Discussion
Sustaining b-cell secretory function in the face of obesity and insulin
resistance is assumed to place aheavy demand on the b-cell ER
27.E R
stress has been implicated in b-cell failure in diet-induced and gen-
etic mouse models of diabetes
21,28–30, and in human patients
22.
However, the dynamic responses of b-cells to increased insulin
demand during the development of insulin resistance is not well
understood, in part due to limitations in the reagents required to
study ATF6a, sXBP1, and P-eIF2a in vivo.
Here, we used recently developed antibodies and staining tech-
niques
31 to investigate UPR modulation in mice with genetic and
diet-induced obesity and insulin resistance. We found that in the
genetic model (ob/ob), disruption of the UPR was detectable in b-
cells prior to the onset of hyperglycemia, likely due to the increased
demandforinsulinproduction.Inthismodel,theUPRresponsewas
insufficienttosustainb-cellfunctionalcapacity,anddeficiencyofthe
ATF6 and sXBP1 arms was pronounced in 8-week-old mice with
insulin resistance. Remarkably, expression of these UPR markers
resolved following the transition of ob/ob mice to a euglycemic state,
likely indicating a lower level of ER stress within individual b-cells
due to the expansion of b-cell mass at this age. In contrast, the pre-
diabetic stage of the HFD model was marked by an upregulation of
sXBP1,perhaps indicating thatb-cellswerecapableofresponding to
mild dietary stress by activating UPR pathways. However, as in the
genetic model, once HFD-fed mice progressed to hyperglycemia,
there was a significant decrease in the level of ATF6, indicating
failure of the b-cell UPR to compensate for the ongoing insulin
demand. A similar general trend was observed in our analysis of
human tissue samples, in which deficiency of UPR component
expression was associated with the diabetic phenotype.
Figure 3 | Expression of UPR mediators in the islets of type 2 diabetic humans. (a). Pancreas sections from non-diabetic and diabetic patients were
obtained from nPOD and co-stained with anti-ATF6a (red), and anti-insulin (green) antibodies (upper panel) and 10–20 islets per sample were
quantifiedbyMATLABH(lowerpanel).(b).Pancreassectionsfromnon-diabeticanddiabeticsubjectsco-stainedwithanti-sXBP1(red)andanti-insulin
(green) antibodies (upper panel) and 10–20 islets per sample were quantified by MATLABH (lower panel). (c). Pancreas sections from non-diabetic and
diabetic subjects co-stained with anti-P-eIF2a (red) and anti-insulin (green) antibodies (upper panel) and 10–20 islets per sample per time point were
quantified by MATLABH (lower panel). All data are presented as mean 6 SEM, with statistical analysis performed by one-way ANOVA (***p , 0.001,
**p , 0.005, *p , 0.05).
www.nature.com/scientificreports
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andsXBP-1, we observed relatively highexpression of the third UPR
branch (P-eIF2a)i na-cells of mouse islets, and states of hypergly-
cemia were associated with increased eIF2a phosphorylation.
Models of hyperglycemica including ob/ob mice and HFD-fed rats
have previously been shown to be hyperglucagonemic
32,33, as have
human subjects with impaired glucose tolerance
34. Thus our obser-
vation of increased eIF2a phosphorylation in the setting of hyper-
glycemia mayreflect anadaptive response withina-cellsto thestress
associated with increased production of glucagon. Alternatively, it
maybepossiblethatdifferentisletcelltypesthatareincontactwithin
the same microenvironment transfer stress signals, and that b-cell
stress induces adaptive responses in neighboring cells. The level of
eIF2a phosphorylation was decreased in human diabetic samples,
which may highlight a difference in the adaptive capacity of this
lineage between mice and humans, although there are limitations
in these human studies that limit our interpretation and will require
further investigation.
A recent study from Chan et al.
35 investigated the expression of
UPRmarkersinisletsisolatedfromdb/dbandob/obmiceat6and16
weeks of age, demonstrating that ER chaperones and the distal med-
iators of UPR declined with time in db/db islets but were maintained
or increased at 16 weeks in ob/ob islets. In contrast, we observed
decreased expression of UPR mediators within ob/ob islets during
the hyperglycemic stage, and normalization in euglycemic 18 week-
old animals. These differences may be related to the timing of ana-
lysis in our study, or may reflect differential regulation of these
mediators at the RNA and protein level. In addition, it may be dif-
ficult to reconcile our in situ analysis with measurements in islets ex
vivo, because the islet isolation process may itself alter stress res-
ponses. However, taken together with previously reported studies,
thedatapresentedheresupportamodelinwhichERstressisevident
in betacells at earlier stages of disease and continuous beta cell stress
thatcannotbemetwithacontinuousandproductiveUPRinthelong
term may lead to the demise of these cells. Finally, the defective
patterns of some UPR branches appears to be a shared pathology
between type 1 and type 2 diabetes
31.
We believe that this work represents an important advance in the
understanding of the dynamic responses of islet cells to the stress
associated with the development of insulin resistance and diabetes.
However, further investigation and interventional studies will be
required to understand how alterations in specific branches of the
UPR affect islet function. In addition, due to the small sample size
available for the analysis, in our human studies we are not currently
able to determine whether UPR component expression declines as a
marker or driver of b-cell failure. This notwithstanding, the broad
agreementbetweenourobservationsinanimalmodelsandinhuman
samplessupportthehypothesisthatERstressplaysanimportantrole
intype2diabetesinhumans,andthatadeclineinadaptiveresponses
within b-cells underlies the progression of the disease. In addition to
itsroleinb-cells,ERstressalsounderliesthedevelopmentofobesity-
induced insulin resistance in othertissues
2,36–38.Thus, itwill beinter-
esting to determine if chemical chaperone treatment is an effective
strategy tomanage both bfunction andperipheral insulin sensitivity
in diabetes, both type 1 and type 2
31,39,40.
Methods
Human pancreatic tissue. Paraffin embedded pancreatic sections from female
cadaveric donors including non-diabetic controls and type 2 diabetes patients were
obtained from the Juvenile Diabetes Research Foundation (JDRF)-sponsored
Network for Pancreatic Organ Donors with Diabetes (nPOD) program (http://www.
jdrfnpod.org/for-investigators/online-pathology-information/). Insulin positive
(Ins1) b-cells were used for staining and quantification. Information regarding the
human tissue donors is in Table 1.
Mouse models. The animal care and experimental procedures were performed in
accordance and with approval from animal care committees of Harvard University.
Male C57/BL6 and homozygous B6.V-Lep
ob/J (ob/ob) mice were purchased from
Jackson Labs. C57BL/6J mice used in the diet-induced obesity model were placed on
high fat diet (Research Diets: D12492) at 10 weeks of age for the indicated period of
time.
Histological analyses. Pancreata from C57/BL6 and ob/ob mice were dissected,
formalin fixed, and paraffin embedded. Antigen retrieval was performed on 5 mm
serial sections of the pancreata by heating the sections in citrate buffer (pH: 6) for
20 mins. Sections were blocked with 5% normal goat serum in phosphate buffered
saline(PBS)for30 mins andincubatedwithprimaryantibodies:anti-insulin(15200,
Linco)2 hatroomtemperature,anti-ATF6a(1520,SantaCruzBiotechnology),anti-
sXBP1 (1520, in house, rabbit poly-clonal), and anti- P-eIF2a (1520, Invitrogen) at
4uC overnight. Sections were then incubated for 2 h at room temperature with goat
anti-guinea Alexa 488 or with goat anti-rabbit Alexa 568 (15200, Invitrogen
MolecularProbes)inPBS.SamplesweremountedinVectashieldmediumwithDAPI
(Vector Laboratories) for viewing with a Zeiss Apotome system. ATF6 and sXBP1
immunostaining was validated using b-cell deletion models for both genes as
previously described
31.
Image analysis. Image analysis was performed by using custom software developed
by MATLABH (The Mathworks, Inc.). Briefly, islet regions were identified as
contiguous areas (connected pixels) of insulin staining (green channel) at or above a
threshold intensity value optimized across multiple images. Data acquisition was
automated,andmeanfluorescenceintensityforinsulin(greenchannel)andforeither
sXBP1, ATF6 or P-eIF2a(red channel) was calculated as the sum of intensities for all
pixels divided by the number of pixels within the islet.
Statistical analysis. Analysis of data was performed using the program GraphPad
Prism. Data are represented as the means 6 SEM and analyzed using Student’s t test
and one-way ANOVA with Tukey’s post test. P , 0.05 was considered statistically
significant.
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